Skip to main content
News Icon

News categories: Publication

Microtubules control migrating cells

Scientists from the Cluster of Excellence ImmunoSensation and the Institute of Science and Technology Austria published their recent findings about microtubules controling migrating cells in the Journal of Cell Biology. Cells need to navigate throughout the body. How they find their right way and how they adapt their body size to moving into the right direction is poorly understood. Here, scientists demonstrate that spatially distinct microtubule dynamics regulate amoeboid cell migration by locally promoting the retraction of protrusions. Prof. Eva Kiermaier is member of the Cluster of Excellence ImmunoSensation2.


The group of Eva Kiermaier focuses on the contribution of the cytoskeleton during innate and adaptive immune responses. Dendritic cells (DCs) represent the most potent antigen presenting cells of the innate immune system. They are key mediators for the induction of protective immunity as well as maintenance of self-tolerance. As such, DCs represent an outstanding population of cells, which mediate three fundamentally important tasks: antigen capture and presentation, migration and T cell activation. The group studies how cytoskeletal components, in particular centrosomes and microtubules, impact immune cell effector functions such as antigen presentation and migration and their behavior upon lymphocyte cell-cell interactions.

Related news

News Icon

News categories: Publication

New vulnerability of asthma immune cells discovered

Why do certain immune cells remain permanently active in allergic asthma – even in an environment that should actually damage them? A team from the University Hospital Bonn (UKB) and the University of Bonn has discovered that these cells only survive because they activate a special antioxidant protection mechanism. When this mechanism is blocked, allergic inflammation in mouse models decreases significantly. The results have now been published in the scientific journal Immunity.
View entry
The human P2X4 receptor

News categories: Publication

A starting point for the development of new pain and cancer drugs

The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have now discovered a mechanism that can inhibit this receptor. The results were recently published in the scientific journal Nature Communications and open up a pathway for the development of new drugs. A study carried out by the University of Bonn and the University Hospital Bonn throws light on how P2X2 can be inhibited. The results have recently been published in Nature Communications.
View entry
Kato research group

News categories: Publication

Ominous false alarm in the kidney

Bonn researchers have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering a chain reaction. In cooperation with Nanyang Technological University Singapore and the University Hospital Würzburg, among others, the study provides an explanation for how a point mutation in the immune receptor RIG-I transforms the body's defense system into a self-destructive force and causes severe organ-specific autoimmune diseases. The results have now been published in the journal Science Immunology.
View entry

Back to the news overview